… Accordingly, the strains have been used as metrics to evaluate myocardial revascularization
efficiency and predict patient outcomes with heart failure. Previous studies have found both …

… This Focus Issue on heart failure (HF) and cardiomyopathies … ‘Left ventricular remodelling
post-myocardial infarction: … use alternative drug interventions such as sacubitril/valsartan…

… clinical usefulness in the treatment of hypertension and are not currently used in the … valsartan
and valsartan groups, respectively. The interaction between sex and the effect of treatment …

… post-myocardial infarction (MI) in mice was determined 1 hour after oral QGC606 (25 mg/kg)
or firibastat (150 mg/kg) treatment … disulfide bridge, 10 we used a similar strategy to increase …

… life-threatening arrhythmias and congestive heart failure as … as well as heart failure, is
frequently accompanied by signs of … These are used mainly as an alternative in patients who can’…

… patients with ST-segment elevation myocardial infarction (STEMI) develop adverse LV
remodeling and post-infarct heart failure… possible directions for the use of myocardial scintigraphy …

… Sacubitril-valsartan should not be used in patients with a history of angioedema in … of
post-myocardial infarction (MI) ventricular remodeling in which treatment with sacubitril-valsartan …

… , in patients with acute myocardial infarction (MI) without type 2 diabetes (T2D) or heart failure
(… death or hospitalization for HF (10.9% sacubitril/valsartan vs. 11.8% ramipril) was twofold …

… For the this study, target doses for the most commonly used ARB were as follows: valsartan
320 mg/d… Are hospitalized or ambulatory patients with heart failure treated in accordance with …

… and day 42 of post-myocardial infarction simulation The combination drug valsartan/sacubitril
(… used to improve cardiac function in patients with heart failure. The model predicts that the …